Leo Pharma reveals favorable information from a Stage 3 research in people aged 12-17 years with delgocitinib, a lotion therapy for serious persistent hand dermatitis.
发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/leo-pharma-achieves-positive-results-in-phase-3-study-of-eczema-cream-for-adolescents/